Flagship Harbor Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$327K Hold
5,100
0.02% 580
2025
Q1
$324K Hold
5,100
0.02% 549
2024
Q4
$339K Sell
5,100
-3,041
-37% -$202K 0.02% 541
2024
Q3
$568K Buy
+8,141
New +$568K 0.03% 382
2024
Q1
$527K Hold
8,141
0.03% 370
2023
Q4
$536K Sell
8,141
-100
-1% -$6.58K 0.04% 345
2023
Q3
$470K Sell
8,241
-50
-0.6% -$2.85K 0.04% 345
2023
Q2
$508K Sell
8,291
-75
-0.9% -$4.6K 0.04% 331
2023
Q1
$525K Sell
8,366
-275
-3% -$17.3K 0.05% 341
2022
Q4
$549K Hold
8,641
0.06% 314
2022
Q3
$509K Sell
8,641
-1,050
-11% -$61.9K 0.06% 304
2022
Q2
$560K Sell
9,691
-875
-8% -$50.6K 0.06% 306
2022
Q1
$655K Sell
10,566
-1,615
-13% -$100K 0.06% 296
2021
Q4
$867K Buy
12,181
+315
+3% +$22.4K 0.08% 252
2021
Q3
$918K Hold
11,866
0.1% 220
2021
Q2
$918K Sell
11,866
-185
-2% -$14.3K 0.1% 221
2021
Q1
$890K Buy
12,051
+500
+4% +$36.9K 0.1% 219
2020
Q4
$810K Sell
11,551
-75
-0.6% -$5.26K 0.1% 217
2020
Q3
$658K Buy
11,626
+2,385
+26% +$135K 0.09% 217
2020
Q2
$538K Buy
9,241
+1,100
+14% +$64K 0.08% 240
2020
Q1
$379K Hold
8,141
0.08% 250
2019
Q4
$455K Hold
8,141
0.08% 247
2019
Q3
$385K Hold
8,141
0.08% 264
2019
Q2
$435K Hold
8,141
0.09% 229
2019
Q1
$449K Hold
8,141
0.09% 232
2018
Q4
$383K Hold
8,141
0.09% 230
2018
Q3
$478K Hold
8,141
0.09% 239
2018
Q2
$445K Hold
8,141
0.09% 238
2018
Q1
$383K Hold
8,141
0.11% 212
2017
Q4
$393K Hold
8,141
0.11% 208
2017
Q3
$408K Hold
8,141
0.13% 193
2017
Q2
$373K Hold
8,141
0.13% 193
2017
Q1
$335K Hold
8,141
0.13% 199
2016
Q4
$324K Buy
+8,141
New +$324K 0.14% 183